Ranbaxy’s problems with the US FDA were ratcheted up a notch yesterday when the agency halted its review of products made at the firm’s plant in Paonta Sahib, India after uncovering “untrue stateme...
The FDA has issued generics giant Ranbaxy Laboratories with two warning letters, detailing “extensive deviations from US cGMP requirements” at the firm’s manufacturing plants in Dewas and Paonta Sa...
Ranbaxy Laboratories has hired Rudy Giuliani, the former mayor of New York, to assist it in overcoming its recent issues with the US Food and Drug Administration (FDA).
Dipity
Update Sources Now
Comments